Literature DB >> 26581611

Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein.

Di-Yi Wang1, Li-Ping Zou2, Xiao-Jia Liu3, Hong-Guang Zhu3, Rong Zhu3.   

Abstract

The hepatitis B virus X protein (HBx), which is encoded by hepatitis B virus (HBV), plays crucial roles in the tumorigenesis of HBV associated hepatocellular carcinoma (HCC). Recent studies suggest that the HBx is involved in regulation of host immune cytokines and chemokines in HBV-associated HCC patients. However, effects of the HBx on autocrine chemokine expression profiles of hepatoma cells, which were shown in modulation of tumor-immune cell interactions, have not been investigated comprehensively. In the present study, human hepatoma cell lines SMMC-7721 and HepG2 were transfected with HBx-expressing plasmid. Human chemokine antibody array 1 (RayBio®), which simultaneously detects 38 chemokine factors, was used to determine chemokine expression profiles. Real-time polymerase chain reaction (real-time PCR) was used to further confirm the differential expression of chemokines. Chemokine antibody array revealed that all 38 chomekines were found to be expressed by SMMC-7721 and HepG2 cell lines. Interleukin-8 (IL-8) was obviously up-regulated, and epithelial neutrophil-activating protein 78 (ENA78), eosinophil chemotactic protein-1 (Eotaxin-1), monocyte chemotactic protein-1 (MCP-1), MCP-2, MCP-3 and macrophage inflammatory protein-3β (MIP-3β) were significantly declined in both cell lines following transfection of HBx-expressing plasmid. Other chemokines showed little or no significant changes. HBx-induced differential chemokine expression levels were validated by real-time PCR. Hierarchical cluster analysis identified a distinction of chomekine expression profiles between HBX-expressing hepatoma cell lines and controls. Our findings provide new evidence that HBx is able to selectively regulate chomekines in hepatoma cells that may be involved in the regulation of tumor-immune cell interactions.

Entities:  

Keywords:  Chemokine antibody array; Chemokines; Hepatitis B virus X protein; Interleukin-8

Mesh:

Substances:

Year:  2015        PMID: 26581611     DOI: 10.1007/s12253-015-0014-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  31 in total

1.  CC motif chemokine ligand 19 suppressed colorectal cancer in vivo accompanied by an increase in IL-12 and IFN-γ.

Authors:  Jun Lu; Junjun Ma; Wei Cai; Xiongzhi Wangpu; Hao Feng; Jingkun Zhao; Shaopei Guan; Yaping Zong; Aiguo Lu
Journal:  Biomed Pharmacother       Date:  2014-12-24       Impact factor: 6.529

2.  Differential expression of transforming growth factor-β1 and HBx enhances hepatitis B virus replication and augments host immune cytokines and chemokines.

Authors:  Fahad N Almajhdi; Ahmed Y Al-Qudari; Zahid Hussain
Journal:  Ann Hepatol       Date:  2013 May-Jun       Impact factor: 2.400

3.  Neutrophil-rich anaplastic large cell lymphoma expressing interleukin-8.

Authors:  Takuya Miyagawa; Makoto Sugaya; Asako Okada; Yoshihide Asano; Takafumi Kadono; Shinichi Sato
Journal:  Acta Derm Venereol       Date:  2014-11       Impact factor: 4.437

Review 4.  Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors.

Authors:  Ramin Lotfi; James J Lee; Michael T Lotze
Journal:  J Immunother       Date:  2007-01       Impact factor: 4.456

5.  Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.

Authors:  Jong-Baeck Lim; Hye Won Chung
Journal:  Cytokine       Date:  2015-02-14       Impact factor: 3.861

Review 6.  Role of chemokine pathways in hepatobiliary cancer.

Authors:  Josef Ehling; Frank Tacke
Journal:  Cancer Lett       Date:  2015-06-26       Impact factor: 8.679

Review 7.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

8.  Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma.

Authors:  Lia E Perez; Nancy Parquet; Mark Meads; Claudio Anasetti; William Dalton
Journal:  Eur J Haematol       Date:  2009-11-17       Impact factor: 2.997

9.  Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha.

Authors:  Teresa Pollicino; Luigi Bellinghieri; Agnese Restuccia; Giuseppina Raffa; Cristina Musolino; Angela Alibrandi; Diana Teti; Giovanni Raimondo
Journal:  Virology       Date:  2013-07-23       Impact factor: 3.616

10.  The effect of chemokine CC motif ligand 19 on the proliferation and migration of hepatocellular carcinoma.

Authors:  Ke-Qin Luo; Yi-Ni Shi; Ji-Cai Peng
Journal:  Tumour Biol       Date:  2014-09-16
View more
  5 in total

Review 1.  Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review.

Authors:  Enakshi Sivasudhan; Neil Blake; Zhiliang Lu; Jia Meng; Rong Rong
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

2.  Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment.

Authors:  Renyong Guo; Hejun Mao; Xiao Hu; Nengneng Zheng; Dong Yan; Jianqin He; Jiezuan Yang
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

3.  Hepatitis B virus X protein influences enrichment profiles of H3K9me3 on promoter regions in human hepatoma cell lines.

Authors:  Di-Yi Wang; Shu-Hong An; Lei Liu; Shan-Shan Bai; Kai-Xiang Wu; Rong Zhu; Zhao-Jin Wang
Journal:  Oncotarget       Date:  2016-12-20

4.  Hepatitis B virus infection does not affect the clinical outcome of anti-programmed death receptor-1 therapy in advanced solid malignancies: Real-world evidence from a retrospective study using propensity score matching.

Authors:  Liting Zhong; PinShun Zhong; Huafeng Liu; Zelei Li; Qihong Nie; Weiwei Peng
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

Review 5.  Hepatitis B virus X protein in liver tumor microenvironment.

Authors:  Sha Fu; Rong-Rong Zhou; Ning Li; Yan Huang; Xue-Gong Fan
Journal:  Tumour Biol       Date:  2016-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.